MWNA
IMDZ

Marshall Wace North America’s Immune Design Corp. IMDZ Stock Holding History

Marshall Wace North America’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-17,959
Closed -$82K – 1645
2018
Q2 		$82K Sell
17,959
-137,905
-88% -$549K ﹤0.01% 1326
2018
Q1 		$514K Sell
155,864
-333,069
-68% -$1.18M ﹤0.01% 1146
2017
Q4 		$1.91M Buy
+488,933
New +$2.66M 0.01% 843

Other funds holding IMDZ

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace North America's IMDZ Position: Q3 2018 in Review

Marshall Wace North America sold out of Immune Design Corp. (IMDZ) in Q3 2018, closing a stake of 17,959 shares — an estimated $82K sold.

Marshall Wace North America first reported a position in IMDZ in Q4 2017 and held it in 3 quarters. The position peaked at $1.91M in Q4 2017. 71 funds tracked by Wall St. Rank hold IMDZ as of Q3 2018.

  • Marshall Wace North America reported no remaining Immune Design Corp. position as of Q3 2018 after selling out during the quarter.
  • Marshall Wace North America sold 17,959 Immune Design Corp. shares in Q3 2018, an estimated $82K.
  • Marshall Wace North America first reported a position in Immune Design Corp. in Q4 2017 and held it in 3 quarters.
  • Marshall Wace North America's Immune Design Corp. position peaked at $1.91M in Q4 2017.
  • 71 funds tracked by Wall St. Rank held Immune Design Corp. as of Q3 2018.

Based on Marshall Wace North America's 13F filing for Q3 2018, filed 14 Nov 2018.